Here we tested the role of EP2 signaling in allergic asthma.
Wild-type (WT) and EP2鈭?鈭?/sup> mice were subjected to ovalbumin sensitization and acute airway challenge. The PGE2 analog misoprostol was administered during sensitization in both genotypes. In聽vitro culture of splenocytes and flow-sorted dendritic cells and T cells defined the mechanism by which EP2 exerted its protective effect. Adoptive transfer of WT and EP2鈭?鈭?/sup> CD4 T cells was used to validate the importance of EP2 expression on T cells. Compared with WT mice, EP2鈭?鈭?/sup> mice had exaggerated airway inflammation in this model. Splenocytes and lung lymph node cells from sensitized EP2鈭?鈭?/sup> mice produced more IL-13 than did WT cells, suggesting increased sensitization. In WT but not EP2鈭?鈭?/sup> mice, subcutaneous administration of misoprostol during sensitization inhibited allergic inflammation. PGE2 decreased cytokine production and inhibited signal transducer and activator of transcription 6 phosphorylation by CD3/CD28-stimulated CD4+ T cells. Coculture of flow cytometry-sorted splenic CD4+ T cells and CD11c+ dendritic cells from WT or EP2鈭?鈭?/sup> mice suggested that the increased IL-13 production in EP2鈭?鈭?/sup> mice was due to the lack of EP2 specifically on T cells. Adoptive transfer of CD4+ EP2鈭?鈭?/sup> T cells caused greater cytokine production in the lungs of WT mice than did transfer of WT CD4+ T cells. We conclude that the PGE2-EP2 axis is an important endogenous brake on allergic airway inflammation and primarily targets T cells and that its agonism represents a potential novel therapeutic approach to asthma.Results
Conclusion